Researchers examined the functional role of regulated in development and DNA damage responses 1 (REDD1), an inhibitor of mammalian target of rapamycin complex 1, in low-dose metronomic chemotherapy-mediated endothelial cell dysfunction.
[Experimental and Molecular Medicine]
7992332
{7992332:AAAAAAAA}
apa
50
1
168170
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/